Compound: aniracetam
SMILES: O=C1N(C(=O)c2ccc(OC)cc2)CCC1
InChIKey: ZXNRTKGTQJPIJK-UHFFFAOYSA-N
Synonyms: aniracetam, 72432-10-1, Draganon, Sarpul, 1-(4-Methoxybenzoyl)-2-pyrrolidinone, Ro 13-5057, 1-p-Anisoyl-2-pyrrolidinone, Ro-13-5057, 1-anisoyl-2-pyrrolidinone, 1-p-anisoylpyrrolidin-2-one, NSC-758223, DTXSID5045128, 5L16LKN964, Ro-135057, DTXCID3025128, CHEBI:47943, 1-[(4-methoxyphenyl)carbonyl]pyrrolidin-2-one, 1-((4-methoxyphenyl)carbonyl)pyrrolidin-2-one, aniracetamum, RefChem:558129, N06BX11, 1-(4-methoxybenzoyl)pyrrolidin-2-one, Ampamet, 2-Pyrrolidinone, 1-(4-methoxybenzoyl)-, MFCD00153767, MLS000079240, aniracetam;p-methoxybenzoyl-2-pirrolidone, NCGC00015116-10, SMR000038438, Aniracetamun, Memodrin, Aniracetamun [INN-Latin], Aniracetam [USAN:INN:JAN], CAS-72432-10-1, SR-01000003147, Ro 135057, BRN 4807205, Sarpol, Reset, UNII-5L16LKN964, Draganon;, Ampamet;, Reset;, 1-(p-Methoxybenzoyl)-2-pyrrolidinon [German], 1-(p-Methoxybenzoyl)-2-pyrrolidinon, Aniracetam (Standard), Spectrum_001342, Tocris-0867, Aniracetam, >=98%, ANIRACETAM [MI], Opera_ID_294, ANIRACETAM [INN], ANIRACETAM [JAN], Spectrum3_001553, Spectrum4_000761, Spectrum5_001609, ANIRACETAM [USAN], Lopac-A-9950, Biomol-NT_000222, ANIRACETAM [MART.], ANIRACETAM [WHO-DD], Lopac0_000115, SCHEMBL70998, BSPBio_003026, KBioGR_001142, KBioSS_001822, MLS000028591, MLS001201800, Aniracetam (JAN/USAN/INN), CHEMBL36994, DivK1c_000403, SPECTRUM1503078, Aniracetam - Bio-X trade mark, BPBio1_001316, GTPL4133, orb1224140, orb1310712, SCHEMBL11379053, HMS501E05, KBio1_000403, KBio2_001822, KBio2_004390, KBio2_006958, KBio3_002526, NINDS_000403, GLXC-06465, HMS2089O17, HMS2094K07, HMS2234E11, HMS3260G12, HMS3266L08, HMS3411P17, HMS3657G11, HMS3675P17, HMS3713N20, HMS3884C09, HMS5079L05, Pharmakon1600-01503078, MSK10891, Tox21_110086, Tox21_500115, 1-(4-Methoxybenzoyl)-2-pyrrolidone, HB0116, HY-10932R, NSC758223, s1281, 1-(p-methoxybenzoyl)-2-pyrrolidinone, AKOS005066313, Tox21_110086_1, AB04115, CCG-204210, CS-1793, DB04599, FA17937, KS-5313, LP00115, NSC 758223, SDCCGSBI-0050103.P005, IDI1_000403, NCGC00015116-01, NCGC00015116-02, NCGC00015116-03, NCGC00015116-04, NCGC00015116-05, NCGC00015116-06, NCGC00015116-07, NCGC00015116-08, NCGC00015116-09, NCGC00015116-11, NCGC00015116-12, NCGC00015116-13, NCGC00015116-24, NCGC00021402-02, NCGC00021402-05, NCGC00021402-06, NCGC00021402-07, NCGC00021402-08, NCGC00260800-01, Ro-13-3057, 1-(4-Methoxy-benzoyl)-pyrrolidin-2-one, 1-(4-Methoxybenzoyl)-2-pyrrolidinone #, AC-15651, BA164183, HY-10932, SY052612, SBI-0050103.P004, A2394, EU-0100115, NS00017748, SW199095-2, A 9950, D01883, H10883, AB00053303-14, AB00053303_15, AB00053303_16, ANIRACETAM; 1-P-ANISOYL-2-PYRROLIDINONE, F859371, Q417630, SR-01000003147-2, SR-01000003147-4, SR-01000003147-6, SR-01000003147-8, BRD-K88611939-001-02-6, BRD-K88611939-001-13-3, BRD-K88611939-001-22-4, BRD-K88611939-001-23-2
Theoretical properties:
molecular_formula: C12H13NO3
molecular_weight: 219.24 g/mol
exact_mass: 219.08954328 g/mol
formal_charge: 0
hydrogen_bond_donor_count: 0
hydrogen_bond_acceptor_count: 3
rotatable_bond_count: 2
heavy_atom_count: 16
topological_polar_surface_area: 46.6 Å²
isotope_atom_count: 0
covalently_bonded_unit_count: 1
Physical properties:
Descriptions:
pubchem: Aniracetam is a N-acylpyrrolidine and a member of pyrrolidin-2-ones.
chembl: ANIRACETAM is a small molecule listed in the ChEMBL database and has reached clinical trial phase 2.0.
wikipedia: Aniracetam (brand names Draganon, Sarpul, Ampamet, Memodrin, Referan), also known as N-anisoyl-2-pyrrolidinone, is a racetam which is sold in Europe as a prescription drug. It is not approved by the Food and Drug Administration for use in the United States as a prescription medication or dietary supplement. Despite the FDA's lack of approval, the drug is readily available over-the-counter in misbranded dietary supplements.